Kossan Rubber Industries Bhd (KSRBF)
USD 0.34
(26.19%)
USD 0.34
(26.19%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.59 Billion MYR | -32.12% |
| 2022 | 2.34 Billion MYR | -64.66% |
| 2021 | 6.63 Billion MYR | 82.26% |
| 2020 | 3.63 Billion MYR | 64.1% |
| 2019 | 2.21 Billion MYR | 3.58% |
| 2018 | 2.14 Billion MYR | 9.35% |
| 2017 | 1.95 Billion MYR | 17.36% |
| 2016 | 1.66 Billion MYR | 1.74% |
| 2015 | 1.63 Billion MYR | 25.95% |
| 2014 | 1.3 Billion MYR | -0.42% |
| 2013 | 1.3 Billion MYR | 5.94% |
| 2012 | 1.23 Billion MYR | 13.21% |
| 2011 | 1.08 Billion MYR | 4.12% |
| 2010 | 1.04 Billion MYR | 24.31% |
| 2009 | 842.13 Million MYR | -6.14% |
| 2008 | 897.19 Million MYR | 27.69% |
| 2007 | 702.63 Million MYR | 22.99% |
| 2006 | 571.28 Million MYR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 429.9 Million MYR | -4.81% |
| 2024 Q1 | 451.62 Million MYR | 12.86% |
| 2023 Q4 | 400.14 Million MYR | -0.83% |
| 2023 Q2 | 387.54 Million MYR | -1.82% |
| 2023 Q3 | 403.47 Million MYR | 4.11% |
| 2023 FY | 1.59 Billion MYR | -32.12% |
| 2023 Q1 | 394.7 Million MYR | -22.45% |
| 2022 Q3 | 560.51 Million MYR | -4.97% |
| 2022 Q1 | 690.63 Million MYR | -23.14% |
| 2022 FY | 2.34 Billion MYR | -64.66% |
| 2022 Q4 | 508.98 Million MYR | -9.19% |
| 2022 Q2 | 589.85 Million MYR | -14.59% |
| 2021 Q1 | 2.19 Billion MYR | 69.67% |
| 2021 Q2 | 2.23 Billion MYR | 2.09% |
| 2021 FY | 6.63 Billion MYR | 82.26% |
| 2021 Q3 | 1.3 Billion MYR | -41.79% |
| 2021 Q4 | 898.53 Million MYR | -31.03% |
| 2020 Q3 | 1.03 Billion MYR | 47.27% |
| 2020 Q2 | 701.68 Million MYR | 14.75% |
| 2020 Q1 | 611.46 Million MYR | 6.54% |
| 2020 Q4 | 1.29 Billion MYR | 25.03% |
| 2020 FY | 3.63 Billion MYR | 64.1% |
| 2019 Q3 | 531.25 Million MYR | -3.5% |
| 2019 Q2 | 550.53 Million MYR | -1.95% |
| 2019 Q4 | 573.91 Million MYR | 8.03% |
| 2019 FY | 2.21 Billion MYR | 3.58% |
| 2019 Q1 | 561.46 Million MYR | -4.14% |
| 2018 FY | 2.14 Billion MYR | 9.35% |
| 2018 Q4 | 585.7 Million MYR | 2.06% |
| 2018 Q3 | 573.89 Million MYR | 15.52% |
| 2018 Q2 | 496.78 Million MYR | 2.6% |
| 2018 Q1 | 484.17 Million MYR | 1.3% |
| 2017 FY | 1.95 Billion MYR | 17.36% |
| 2017 Q4 | 477.95 Million MYR | -2.29% |
| 2017 Q3 | 489.18 Million MYR | -0.27% |
| 2017 Q2 | 490.51 Million MYR | -1.89% |
| 2017 Q1 | 499.97 Million MYR | 14.18% |
| 2016 Q2 | 403.77 Million MYR | -2.06% |
| 2016 FY | 1.66 Billion MYR | 1.74% |
| 2016 Q1 | 412.28 Million MYR | -6.88% |
| 2016 Q4 | 437.9 Million MYR | 5.76% |
| 2016 Q3 | 414.03 Million MYR | 2.54% |
| 2015 Q4 | 442.73 Million MYR | 0.22% |
| 2015 Q3 | 441.74 Million MYR | 14.51% |
| 2015 FY | 1.63 Billion MYR | 25.95% |
| 2015 Q1 | 369.25 Million MYR | 1.62% |
| 2015 Q2 | 385.77 Million MYR | 4.47% |
| 2014 Q2 | 303.82 Million MYR | -0.77% |
| 2014 Q1 | 306.17 Million MYR | -5.76% |
| 2014 Q4 | 363.38 Million MYR | 10.67% |
| 2014 FY | 1.3 Billion MYR | -0.42% |
| 2014 Q3 | 328.35 Million MYR | 8.07% |
| 2013 Q2 | 321.57 Million MYR | -1.74% |
| 2013 Q4 | 324.9 Million MYR | -2.59% |
| 2013 FY | 1.3 Billion MYR | 5.94% |
| 2013 Q1 | 327.26 Million MYR | 3.21% |
| 2013 Q3 | 333.54 Million MYR | 3.72% |
| 2012 Q1 | 289.43 Million MYR | 0.0% |
| 2012 FY | 1.23 Billion MYR | 13.21% |
| 2012 Q2 | 304.75 Million MYR | 5.29% |
| 2012 Q3 | 322.73 Million MYR | 5.9% |
| 2012 Q4 | 317.08 Million MYR | -1.75% |
| 2011 FY | 1.08 Billion MYR | 4.12% |
| 2010 FY | 1.04 Billion MYR | 24.31% |
| 2009 FY | 842.13 Million MYR | -6.14% |
| 2008 FY | 897.19 Million MYR | 27.69% |
| 2007 FY | 702.63 Million MYR | 22.99% |
| 2006 FY | 571.28 Million MYR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -49752.921% |
| Ansell Limited | 1.61 Billion USD | 1.745% |
| Ansell Limited | 1.61 Billion USD | 1.745% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -761.665% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -1177970.416% |
| Psykey, Inc. | 419.29 Thousand USD | -379353.087% |
| ConvaTec Group Plc | 2.19 Billion USD | 27.483% |
| ConvaTec Group Plc | 2.14 Billion USD | 25.735% |
| Encision Inc. | 6.58 Million USD | -24058.389% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -87084.021% |
| LifePoint, Inc. | -18.5 Thousand USD | 8600332.432% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -23253.046% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -205993.653% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -161227.391% |
| Reflect Scientific, Inc. | 1.08 Million USD | -147197.793% |
| SmileDirectClub, Inc. | 470.74 Million USD | -237.985% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 14.991% |
| SheerVision, Inc. | 3.49 Million USD | -45366.075% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -114669.522% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -213436.163% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -1525597.381% |